| Abbott (23) |  |
| Amgen (10) | |
| Astra-merck (6) | |
| Bayer (41) | |
| Boehringer-ingelheim (1) | |
| Bristol-myers-squibb (5) | |
| Dupont-merck (14) | |
| Eli lilly (5) | |
| Genentech (5) | |
| Genzyme (5) | |
| Glaxosmithkline (26) | |
| Hoechst-marion-roussel (4) | |
| Pasteur-merieux (8) | |
| Pfizer (22) | |
| Pharmaceutical industry (36) | |
| Pharmaceutical laboratory (1) | |
| Pharmacyclics (1) | |
| Roche pharmaceuticals (16) | |
| Sanofi-aventis (6) | |
| Stallergenes (1) | |
| Whitehall laboratories (3) | |
#Art Levinson will remain Chairman of Genentech and a director of Hoffmann-la roche, as well as Chairman of Apple.
Chairman of Hoffmann-la roche, said:##oeart s track record at Genentech has been exemplary, and we see an interesting potential for our companies to work together going forward.
Don't forget to think about antibiotics said study researcher Dr. Anne Des Roches an allergist at CHU Sainte-Justine a health center affiliated with the University of Montreal in Quebec.
they have to send the sample to special laboratories to perform an analysis Des Roches said.
including oseltamivir (marketed by Roche as Tamiflu) and zanamivir (marketed by Glaxosmithkline as Relenza), are effective against the new pandemic virus in human cells grown in the lab. These drugs are already being used to treat some infected patients.
has rejected, as expected a US$5. 7-billion takeover bid by drug giant Roche, based in Basel, Switzerland.
Roche replied that its bid was"full and fair. The firm is expected now to start wooing Illumina's major investors to accept a takeover
even though Illumina's share price is currently well above Roche's bid. Synbio troubles US synthetic biology firm Amyris which engineers microbes to process plant sugars into useful chemicals saw its share price plunge by 28%on 10 february,
Pharma closure About 1, 000 Â jobs are to be lost with the closure of pharmaceutical company Roche s research site in Nutley
Roche said the 80-year-old base would cease operation by the end of 2013;
On the same day, Illumina s share price dropped by 7%after drug giant Roche said that it did not plan to buy the company.
and water quality especially with cattle grazing said lead author Leslie Roche a postdoctoral scholar in the UC Davis Department of Plant sciences.
and support from Roche Applied science's 10 Gigabase Grant Program to understand the unique roles of fungi and bacteria.
As far as we know this is the first report that links an allergic reaction to fruits treated with antibiotic pesticides said allergist Anne Des Roches MDFRCP lead study author.
Another was the sweet orange genome produced jointly by researchers at the DOE JGI the University of Florida and 454 Life sciences a Roche company.
The Mars group used so-called second generation sequencers made by Illumina and 454, a division of Roche.
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011